Gene · 1894
Papers1,404
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,404
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 1,25-Dihydroxyvitamin D3 Suppresses Prognostic Survival Biomarkers Associated with Cell Cycle and Actin Organization in a Non-Malignant African American Prostate Cell Line. | Biology (Basel) | 2024 | 38785827 | PubTator, text mining | PubMed |
| Dbl family RhoGEFs in cancer: different roles and targeting strategies. | Biochem Pharmacol | 2024 | 38499108 | PubTator, text mining | PubMed |
| GINS2 regulates temozolomide chemosensitivity via the EGR1/ECT2 axis in gliomas. | Cell Death Dis | 2024 | 38467631 | PubTator, text mining | PubMed |
| The gene expression of CALD1, CDH2, and POSTN in fibroblast are related to idiopathic pulmonary fibrosis. | Front Immunol | 2024 | 38370408 | PubTator, text mining | PubMed |
| Adverse clinical outcomes and immunosuppressive microenvironment of RHO-GTPase activation pattern in hepatocellular carcinoma. | J Transl Med | 2024 | 38297333 | PubTator, text mining | PubMed |
| SP1-activated USP27X-AS1 promotes hepatocellular carcinoma progression via USP7-mediated AKT stabilisation. | Clin Transl Med | 2024 | 38279869 | PubTator, text mining | PubMed |
| MET fusions are targetable genomic variants in the treatment of advanced malignancies. | Cell Commun Signal | 2024 | 38195556 | PubTator, text mining | PubMed |
| Genome-wide DNA methylation of lesional and peri-lesional skin in vitiligo: a comparative and integrated analysis of multi-omics in Chinese population. | Hum Genet | 2024 | 38182908 | PubTator, text mining | PubMed |
| Role of YAP Signaling in Regulation of Programmed Cell Death and Drug Resistance in Cancer. | Int J Biol Sci | 2024 | 38164167 | PubTator, text mining | PubMed |
| Development of a Combined Oxidative Stress and Endoplasmic Reticulum Stress-Related Prognostic Signature for Hepatocellular Carcinoma. | Comb Chem High Throughput Screen | 2024 | 37957902 | PubTator, text mining | PubMed |
| A Multimodal Omics Framework to Empower Target Discovery for Cardiovascular Regeneration. | Cardiovasc Drugs Ther | 2024 | 37421484 | PubTator, text mining | PubMed |
| OTUB1-mediated inhibition of ubiquitination: a growing list of effectors, multiplex mechanisms, and versatile functions. | Front Mol Biosci | 2023 | 38264570 | PubTator, text mining | PubMed |
| Pathogenesis, clinical features, and treatment of plurihormonal pituitary adenoma. | Front Neurosci | 2023 | 38260014 | PubTator, text mining | PubMed |
| Development and validation of a DNA damage repair-related gene-based prediction model for the prognosis of lung adenocarcinoma. | J Thorac Dis | 2023 | 38249902 | PubTator, text mining | PubMed |
| UBE3A: The Role in Autism Spectrum Disorders (ASDs) and a Potential Candidate for Biomarker Studies and Designing Therapeutic Strategies. | Diseases | 2023 | 38248358 | PubTator, text mining | PubMed |
| Copy Number Variations in Pancreatic Cancer: From Biological Significance to Clinical Utility. | Int J Mol Sci | 2023 | 38203561 | PubTator, text mining | PubMed |
| Comparative Insight into Microglia/Macrophages-Associated Pathways in Glioblastoma and Alzheimer's Disease. | Int J Mol Sci | 2023 | 38203185 | PubTator, text mining | PubMed |
| Identification of potential key genes for colorectal cancer based on bioinformatics analysis. | Medicine (Baltimore) | 2023 | 38134110 | PubTator, text mining | PubMed |
| The Identification of Nuclear FMRP Isoform Iso6 Partners. | Cells | 2023 | 38132127 | PubTator, text mining | PubMed |
| Nkx2.5: a crucial regulator of cardiac development, regeneration and diseases. | Front Cardiovasc Med | 2023 | 38124890 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1894/papers?page=4